Clinical Trial Update: Budesonide With Intratracheal Surfactants in Extremely Preterm Infants [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating budesonide with intratracheal surfactants in extremely preterm infants to address bronchopulmonary dysplasia and respiratory distress…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Respiratory Distress Syndrome in Premature Infants

Drugs mentioned

• Budesonide (BUDESONIDE)

Snippet

Sponsor: University of Manitoba | Conditions: Bronchopulmonary Dysplasia, Respiratory Distress Syndrome in Premature Infant | Phase 1, Phase 2 | Status: UNKNOWN